Could a common drug unlock a new clue for sleep apnea patients?
NCT ID NCT06462287
Summary
This small, early-stage study aims to understand if a drug called aprepitant can lower levels of a hormone called aldosterone in people with severe sleep apnea and high blood pressure. Researchers want to see if blocking a brain chemical called substance P affects this hormone, which might explain why sleep apnea and high blood pressure are often linked. The study will involve 24 participants and compare the effects of aprepitant against a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APNEA, OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Rouen
RECRUITINGRouen, France, 76000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.